Assessment of acetylcholinesterase activity in CD9-positive exosomes from patients with Parkinson’s disease

IntroductionParkinson’s disease (PD) is a neurodegenerative disorder characterized by dopaminergic dysfunction and associated with abnormalities in the cholinergic system. However, the relationship between PD and cholinergic dysfunction, particularly in exosomes, is not fully understood.MethodsWe en...

Full description

Bibliographic Details
Main Authors: Sumin Jeong, Kyu Hwan Shim, Danyeong Kim, Heewon Bae, Da-Eun Jeong, Min Ju Kang, Seong Soo A. An
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2024.1332455/full
_version_ 1797322525980491776
author Sumin Jeong
Sumin Jeong
Kyu Hwan Shim
Danyeong Kim
Danyeong Kim
Heewon Bae
Da-Eun Jeong
Min Ju Kang
Seong Soo A. An
author_facet Sumin Jeong
Sumin Jeong
Kyu Hwan Shim
Danyeong Kim
Danyeong Kim
Heewon Bae
Da-Eun Jeong
Min Ju Kang
Seong Soo A. An
author_sort Sumin Jeong
collection DOAJ
description IntroductionParkinson’s disease (PD) is a neurodegenerative disorder characterized by dopaminergic dysfunction and associated with abnormalities in the cholinergic system. However, the relationship between PD and cholinergic dysfunction, particularly in exosomes, is not fully understood.MethodsWe enrolled 37 patients with PD and 44 healthy controls (HC) to investigate acetylcholinesterase (AChE) activity in CD9-positive and L1CAM-positive exosomes. Exosomes were isolated from plasma using antibody-coupled magnetic beads, and their sizes and concentrations were assessed using transmission electron microscopy, nanoparticle tracking analysis, and western blotting. Subsequently, the AChE activity in these exosomes was analyzed in relation to various clinical parameters.ResultsA significant decrease in AChE activity was observed in CD9-positive exosomes derived from patients with PD, whereas no significant differences were found in L1CAM-positive exosomes. Further analysis with a larger sample size confirmed a substantial reduction in AChE activity in CD9-positive exosomes from the PD plasma, with moderate diagnostic accuracy. The decrease in AChE activity of CD9-positive exosomes did not show an association with cognitive impairment but displayed a trend toward correlation with PD progression.DiscussionThe reduction in AChE activity in CD9-positive exosomes suggests potential peripheral cholinergic dysfunction in PD, independent of the central cholinergic system. The observed alterations in AChE activity provide valuable insights into the association between cholinergic dysfunction and the pathogenesis of PD.
first_indexed 2024-03-08T05:15:33Z
format Article
id doaj.art-e2b46e49284a4e2d99da1c32898918c2
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-03-08T05:15:33Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-e2b46e49284a4e2d99da1c32898918c22024-02-07T04:36:42ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652024-02-011610.3389/fnagi.2024.13324551332455Assessment of acetylcholinesterase activity in CD9-positive exosomes from patients with Parkinson’s diseaseSumin Jeong0Sumin Jeong1Kyu Hwan Shim2Danyeong Kim3Danyeong Kim4Heewon Bae5Da-Eun Jeong6Min Ju Kang7Seong Soo A. An8Department of Bionano Technology, Gachon University, Seongnam, Republic of KoreaDepartment of Neurology, Veterans Health Service Medical Center, Veterans Medical Research Institute, Seoul, Republic of KoreaDepartment of Bionano Technology, Gachon University, Seongnam, Republic of KoreaDepartment of Bionano Technology, Gachon University, Seongnam, Republic of KoreaDepartment of Neurology, Veterans Health Service Medical Center, Veterans Medical Research Institute, Seoul, Republic of KoreaDepartment of Neurology, Veterans Health Service Medical Center, Veterans Medical Research Institute, Seoul, Republic of KoreaDepartment of Neurology, Veterans Health Service Medical Center, Veterans Medical Research Institute, Seoul, Republic of KoreaDepartment of Neurology, Veterans Health Service Medical Center, Veterans Medical Research Institute, Seoul, Republic of KoreaDepartment of Bionano Technology, Gachon University, Seongnam, Republic of KoreaIntroductionParkinson’s disease (PD) is a neurodegenerative disorder characterized by dopaminergic dysfunction and associated with abnormalities in the cholinergic system. However, the relationship between PD and cholinergic dysfunction, particularly in exosomes, is not fully understood.MethodsWe enrolled 37 patients with PD and 44 healthy controls (HC) to investigate acetylcholinesterase (AChE) activity in CD9-positive and L1CAM-positive exosomes. Exosomes were isolated from plasma using antibody-coupled magnetic beads, and their sizes and concentrations were assessed using transmission electron microscopy, nanoparticle tracking analysis, and western blotting. Subsequently, the AChE activity in these exosomes was analyzed in relation to various clinical parameters.ResultsA significant decrease in AChE activity was observed in CD9-positive exosomes derived from patients with PD, whereas no significant differences were found in L1CAM-positive exosomes. Further analysis with a larger sample size confirmed a substantial reduction in AChE activity in CD9-positive exosomes from the PD plasma, with moderate diagnostic accuracy. The decrease in AChE activity of CD9-positive exosomes did not show an association with cognitive impairment but displayed a trend toward correlation with PD progression.DiscussionThe reduction in AChE activity in CD9-positive exosomes suggests potential peripheral cholinergic dysfunction in PD, independent of the central cholinergic system. The observed alterations in AChE activity provide valuable insights into the association between cholinergic dysfunction and the pathogenesis of PD.https://www.frontiersin.org/articles/10.3389/fnagi.2024.1332455/fullParkinson’s diseasebloodacetylcholinesteraseexosomesCD9cholinergic dysfunction
spellingShingle Sumin Jeong
Sumin Jeong
Kyu Hwan Shim
Danyeong Kim
Danyeong Kim
Heewon Bae
Da-Eun Jeong
Min Ju Kang
Seong Soo A. An
Assessment of acetylcholinesterase activity in CD9-positive exosomes from patients with Parkinson’s disease
Frontiers in Aging Neuroscience
Parkinson’s disease
blood
acetylcholinesterase
exosomes
CD9
cholinergic dysfunction
title Assessment of acetylcholinesterase activity in CD9-positive exosomes from patients with Parkinson’s disease
title_full Assessment of acetylcholinesterase activity in CD9-positive exosomes from patients with Parkinson’s disease
title_fullStr Assessment of acetylcholinesterase activity in CD9-positive exosomes from patients with Parkinson’s disease
title_full_unstemmed Assessment of acetylcholinesterase activity in CD9-positive exosomes from patients with Parkinson’s disease
title_short Assessment of acetylcholinesterase activity in CD9-positive exosomes from patients with Parkinson’s disease
title_sort assessment of acetylcholinesterase activity in cd9 positive exosomes from patients with parkinson s disease
topic Parkinson’s disease
blood
acetylcholinesterase
exosomes
CD9
cholinergic dysfunction
url https://www.frontiersin.org/articles/10.3389/fnagi.2024.1332455/full
work_keys_str_mv AT suminjeong assessmentofacetylcholinesteraseactivityincd9positiveexosomesfrompatientswithparkinsonsdisease
AT suminjeong assessmentofacetylcholinesteraseactivityincd9positiveexosomesfrompatientswithparkinsonsdisease
AT kyuhwanshim assessmentofacetylcholinesteraseactivityincd9positiveexosomesfrompatientswithparkinsonsdisease
AT danyeongkim assessmentofacetylcholinesteraseactivityincd9positiveexosomesfrompatientswithparkinsonsdisease
AT danyeongkim assessmentofacetylcholinesteraseactivityincd9positiveexosomesfrompatientswithparkinsonsdisease
AT heewonbae assessmentofacetylcholinesteraseactivityincd9positiveexosomesfrompatientswithparkinsonsdisease
AT daeunjeong assessmentofacetylcholinesteraseactivityincd9positiveexosomesfrompatientswithparkinsonsdisease
AT minjukang assessmentofacetylcholinesteraseactivityincd9positiveexosomesfrompatientswithparkinsonsdisease
AT seongsooaan assessmentofacetylcholinesteraseactivityincd9positiveexosomesfrompatientswithparkinsonsdisease